The VASCULAID consortium is delighted to share an important milestone in the progress of our clinical research activities. The first patients have now been successfully included in the prospective study at the Amsterdam site, marking the transition from preparation to active clinical enrolment within our six participating clinical centres. This milestone demonstrates the project’s steady … Read more
On June 12th and 13th, the VASCUL-AID consortium convened in Belgrade for its second annual meeting—two highly productive days marked by insightful discussions, collaborative planning, and tangible progress across all project work packages. A special thanks to Igor Končar and the local team for the excellent organization and warm hospitality! Day 1: Collaboration, Strategy, and … Read more
“Vascul-aid: A Quick Overview”In this one-minute video, Dr. Kak Khee Yeung, the Principal Investigator, presents an overview of Vascul-aid. This engaging introduction offers insights into our research and mission.
The first year of the VASCUL-AID project flew by and we have achieved so much together already! Great team spirit in the VASCUL-AID project focusing on reducing cardiovascular disease progression in AAA and PAD patients! The VASCUL-AID consortium’s Annual Meeting recently concluded its two-day program in Porto, bringing together a distinguished gathering of researchers from … Read more
Patiëntendag op maandag 11 december Op maandag 11 december 2023 vindt van 11.30 tot 16.00 uur de patiëntendag voor patiënten met etalagebenen (perifeer arterieel vaatlijden) en patiënten met een verwijde grote buikslagader (aorta aneurysma, AAA) plaats in het AMC. Deze patiëntendag staat in het teken van Kunstmatige intelligentie in de zorg. Het nieuwe onderzoek VASCUL-AID … Read more
Welcome to the inaugural blog post of VASCUL-AID! We are thrilled to share with you the exciting journey we have embarked upon in revolutionizing the management of vascular diseases. This project marks a significant milestone in our pursuit of personalized and proactive healthcare. VASCUL-AID was born out of a collective passion to predict the risk … Read more